Founded with a mission to advance the field of surgical oncology, Onkos Surgical is a privately-held company dedicated to providing innovative technology and solutions for surgical oncologists. The company focuses on developing specialized implants and instruments tailored for tumor and revision orthopedic surgeries, including patient-specific 3D printed pelvic reconstruction systems. Onkos Surgical aims to improve patient outcomes by addressing the unique challenges faced in musculoskeletal oncology.
Notable achievements include receiving the first FDA De Novo approval for an antibacterial coating on tumor and revision orthopedic implants, as well as FDA clearance for their 3D printed, patient-specific pelvic reconstruction system. The company has also expanded its capabilities in pediatric musculoskeletal oncology and established a new Manufacturing and Innovation Center. These milestones underscore Onkos Surgical's impact on enhancing surgical oncology practices and improving patient care.
